Filing Flows › Inspire Medical Systems (INSP) › Q3 2026 › vs Q3 2025
Inspire Medical Systems (INSP) Q3 2026 vs Q3 2025 (year over year)
Inspire Medical Systems's revenue fell $17.8M (-8%) from $225M in Q3 2025 to $207M in Q3 2026.
Inspire Medical Systems, Q3 2026: revenue $207M (-8% year over year), operating margin -13.9%, net loss $24.4M, operating cash flow $46.4M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Free cash flow margin | 18.8% | 25.9% | -7.1 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $207M | $225M | −$17.8M | -8% |
| Other income, net | $3.7M | $3.9M | −$201K | -5% |
| Income tax benefit | $616K | −$3.6M | $4.2M | — |
| Net loss | $24.4M | −$9.9M | $34.3M | — |
| Costs & expenses | $235M | $228M | $7.0M | +3% |
| Operating costs | $235M | $215M | $20.6M | +10% |
| Cost of revenue | $28.8M | $31.8M | −$2.9M | -9% |
| Research & development | $22.2M | $24.2M | −$2.0M | -8% |
| SG&A | $184M | $159M | $25.5M | +16% |
| Operating cash sources | $70.8M | $58.6M | $12.2M | +21% |
| Depreciation & amortization | $5.1M | $3.7M | $1.5M | +40% |
| Share-based compensation | $26.9M | $29.5M | −$2.6M | -9% |
| Working capital & other | $38.8M | $25.4M | $13.4M | +53% |
| Net loss absorbed | $24.4M | −$9.9M | $34.3M | — |
| Operating cash flow | $46.4M | $68.5M | −$22.1M | -32% |
| Free cash flow (OCF − capex) | $38.9M | $58.1M | −$19.2M | -33% |
| Capital expenditures | $7.5M | $10.4M | −$2.9M | -28% |
Questions
How much did Inspire Medical Systems's revenue grow year over year in Q3 2026?
Inspire Medical Systems's revenue fell $17.8M (-8%) from $225M in Q3 2025 to $207M in Q3 2026.